CRSP·Healthcare·Biotech
CRISPR Therapeutics Pipeline +3.2%: Cardiology Boom Risk
Can the CRISPR Therapeutics Pipeline in cardiology turn today’s modest gene-editing revenues into a multi-billion-dollar growth story?
Biotech
CRSP·Healthcare·Biotech
BNTX·Healthcare·Biotech
BioNTech Leadership Change: -17.9% Crash After Billion-Euro Loss
Can BioNTech’s surprise leadership change and deepening losses turn a Covid-era star into a long-term oncology value play or a…
MRNA·Healthcare·Biotech
Moderna Patent Settlement +11.3% Surge: Is the $2.25B Hit Worth the Clarity?
Does Moderna’s billion‑dollar patent peace deal finally clear the runway for its mRNA pipeline—or just cap the upside? Moderna Patent…